Coagulation Market Research Reports & Industry Analysis
Coagulation factors have been implicated as independent factors in the development of myocardial infarction, stroke and deep vein thrombosis in some patients. With the increasing incidence of cardiovascular diseases, this discovery has brought what was a rather lackluster discipline into the limelight. The intensive investigation of coagulation processes has uncovered a number of other conditions in which coagulation factors are implicated, such as: post surgical bleeding due to the use of aspirin or Plavix, spontaneous abortion and pregnancy problems.
Demand for rapid decentralized coagulation testing is increasing. The number of patients needing coagulation testing is growing. More patients are using anticoagulants following implantation of mechanical heart valves or after atrial fibrillation. More recently patients are using antithrombotic agents after, or to prevent, deep venous thrombosis, arterial or pulmonary embolism, stroke, angina pectoris, and myocardial infarction. There is also increasing pressure to return results to clinicians rapidly so that anticoagulant therapy can be adjusted.
Coagulation Industry Research & Market Reports
-
2024-2029 Singapore Diagnostics Market for 500 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 500 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, and TDM Tests, Strategic Profiles of Leading Competitors
... Diseases, Molecular Diagnostics, and TDM Tests, Strategic Profiles of Leading Competitors This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2024 supplier shares, strategies, as well as 2024-2029 volume and ... Read More
-
2024-2029 Taiwan Diagnostics Market for 500 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 500 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, and TDM Tests, Strategic Profiles of Leading Competitors
... Diseases, Molecular Diagnostics, and TDM Tests, Strategic Profiles of Leading Competitors This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2024 supplier shares, strategies, as well as 2024-2029 volume and ... Read More
-
2024-2029 Coagulation Market - Segments with Significant Upside - US, Europe, Japan - Supplier Shares and Segment Forecasts by Test - Technological Breakthroughs, Emerging Tests, Competitive Analysis
... current suppliers and potential market entrants identify and evaluate emerging business opportunities and develop effective strategies for the global coagulation testing market during the next five years. The report explores business and technological trends in ... Read More
-
2024-2029 Germany Coagulation Market - Growth Opportunities and Strategies for Hemostasis Analyzers and Reagents - Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation
... designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the German coagulation testing market during the next five years. The report explores business and technological trends in the ... Read More
-
2024-2029 Italy Coagulation Market - Growth Opportunities and Strategies for Hemostasis Analyzers and Reagents - Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation
... designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Italian coagulation testing market during the next five years. The report explores business and technological trends in the ... Read More
-
2024-2029 Europe Coagulation Market - Growth Opportunities and Strategies for Hemostasis Analyzers and Reagents - Europe, France, Italy, Spain, UK - Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation
... Instrumentation Summary This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European coagulation testing market during the next five years. The report ... Read More
-
2024-2029 France Coagulation Market - Growth Opportunities and Strategies for Hemostasis Analyzers and Reagents - Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation
... designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the French coagulation testing market during the next five years. The report explores business and technological trends in the ... Read More
-
2024 Global Coagulation Market Players - Market Shares by Country, Strategic Assessments of Major Suppliers and Emerging Market Entrants
... entrants. The report presents analyses of major manufacturers of coagulation products in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 45 ... Read More
-
D-dimer Testing
... at a CAGR of 4.0% over the analysis period 2023-2030. D-dimer Testing Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$1.3 Billion by ... Read More
-
Hemostasis Diagnostics
... at a CAGR of 4.8% over the analysis period 2023-2030. Prothrombin Test Time (PT), one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.3 Billion by the ... Read More
-
Hemostasis Products
... at a CAGR of 3.8% over the analysis period 2023-2030. Infusible Hemostasis Products, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.6 Billion by the end ... Read More
-
IVD Test Procedure Volumes, 2024-2029
... in The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 17th Edition, this essential report delivers actionable data on the growth, challenges, and emerging opportunities in the IVD space. As a rapidly evolving market, the ... Read More
-
2024-2028 Antithrombin II Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Fibrinogen Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, Germany, ... Read More
-
2024-2028 Global Antithrombin II Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, ... Read More
-
2024-2028 D-Dimer Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, Germany, ... Read More
-
2024-2028 Heparin/Anti-Factor Xa Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Factor Assays Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Heparin-Induced Thrombocytopenia Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
Hemostasis and Tissue Sealing Agents
... is expected to reach US$9.8 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Topical Hemostat, one of the segments analyzed in the report, is expected to record a 8.4% ... Read More
-
Heparin
... of 2.8% over the analysis period 2023-2030. Low Molecular Weight Heparin (LMWH), one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$5.9 Billion by the end of ... Read More
-
Coagulation / Hemostasis Analyzers
... reach US$5.0 Billion by 2030, growing at a CAGR of 3.0% over the analysis period 2023-2030. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and ... Read More
-
Coagulation Factor Concentrates
... at a CAGR of 7.1% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$8.8 Billion by the ... Read More
-
Coagulation Testing
... at a CAGR of 4.7% over the analysis period 2023-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.7 Billion by the end ... Read More
-
Antithrombin
... of 5.2% over the analysis period 2023-2030. Therapeutics Application, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$847.5 Million by the end of the analysis period. ... Read More
Research Assistance
